MECONIUM DRUG SCREENING IN NEWBORN INFANTS
新生儿胎便药物筛查
基本信息
- 批准号:3213540
- 负责人:
- 金额:$ 24.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-07-01 至 1993-06-30
- 项目状态:已结题
- 来源:
- 关键词:cannabinoids cocaine diagnostic tests drug abuse drug metabolism drug screening /evaluation embryo /fetus drug adverse effect female hair human pregnant subject human subject interview longitudinal human study marijuana abuse morphine mother /infant health care newborn human (0-6 weeks) placental transfer pregnancy questionnaires radioimmunoassay statistics /biometry
项目摘要
Recent epidemiological and other survey data suggest that a significant
number of pregnant women and those in child bearing age abuse illicit
drugs, in particular cocaine, with serious consequences such as premature
delivery, low birth weight infants, high infant morbidity and long term
sequelae. Therefore, it is important that these high risk infants are
identified soon after birth, and it possible, the type, degree and duration
of exposure to drugs, in utero. Currently, the methods used to accomplish
this are by maternal self-report or by urine toxicology screen. Studies
have shown that these methods do not consistently provide reliable and
valid exposure data. A new method has been developed that identifies the
drug exposed neonates by analysis of their stools (meconium) for drug
metabolites. The test is quantitative, rapid, non invasive and by far,
more sensitive than the current tests that are available. Since meconium,
unlike urine, is not normally excreted by the fetus in utero, meconium
accumulates in the fetus throughout gestation. Thus, further studies on
meconium may provide details about the maternal drug such as the amount,
timing and duration of her drug abuse. Comprehensive information of this
nature are valuable for epidemiological and clinical purposes and are vital
to our understanding of the complex relationship between drug use during
pregnancy and its effects on the mother and fetus.
The objective of this study is to determine whether the concentration of
drug metabolites in meconium correlate to the amount, timing and duration
of drug use by the mother. To accomplish this, a group of pregnant addicts
who attend our maternal high risk clinic will be selected for follow up
during pregnancy. The amount, time and duration of drug abuse by these
subjects will be monitored throughout gestation by means of in depth
interviews and by maternal hair analyses. Neither maternal nor infant
urine will be tested for this purpose since these tests mostly reflect the
recent use of drugs by the mother. After delivery, meconium that is
serially passed by the infant will be analyzed for the metabolites of
morphine, cocaine, and cannabinoid, three of the most common drugs of
abuse. The individual and cumulative concentrations of each drug
metabolite in meconium will be correlated to the maternal drug use as
obtained from the interview and hair analysis.
This study is designed to develop the potential of meconium drug analysis
as a comprehensive diagnostic test. Currently, there is the need for an
objective and sensitive test during the newborn period which can measure
the type, amount, timing and duration of the infant's exposure to drugs in
utero. An assessment of the potential to achieve this with the meconium
analysis is proposed.
最近的流行病学和其他调查数据表明,
非法虐待孕妇和育龄妇女人数
毒品,特别是可卡因,会造成严重后果,例如早产
分娩、低出生体重婴儿、高婴儿发病率和长期
后遗症。 因此,重要的是这些高危婴儿
出生后不久就确定了,可能的类型、程度和持续时间
在子宫内接触药物。 目前,用于实现的方法
这是通过产妇自我报告或尿液毒理学筛查得出的。 研究
已经表明这些方法并不能始终如一地提供可靠和
有效的曝光数据。 已经开发出一种新方法来识别
通过分析粪便(胎便)中的药物来分析接触药物的新生儿
代谢物。 该测试是定量、快速、非侵入性的,到目前为止,
比当前可用的测试更敏感。 由于胎便,
与尿液不同,胎粪通常不会由子宫内的胎儿排出
在整个妊娠过程中会在胎儿体内积累。 因此,进一步研究
胎便可以提供有关母体药物的详细信息,例如剂量、
她滥用药物的时间和持续时间。 本次综合信息
自然对于流行病学和临床目的很有价值,并且至关重要
加深我们对药物使用之间复杂关系的理解
怀孕及其对母亲和胎儿的影响。
本研究的目的是确定浓度是否
胎便中的药物代谢物与数量、时间和持续时间相关
母亲吸毒的情况。 为了实现这一目标,一群怀孕的瘾君子
我们将选择到我们孕产妇高危诊所就诊的人进行随访
怀孕期间。 这些人滥用药物的数量、时间和持续时间
将通过深入监测受试者整个妊娠期
访谈和母亲头发分析。 无论是母婴还是婴儿
为此目的将测试尿液,因为这些测试主要反映
母亲最近使用过药物。 分娩后,胎便即
将分析婴儿连续通过的代谢物
吗啡、可卡因和大麻素是三种最常见的毒品
虐待。 每种药物的单独浓度和累积浓度
胎粪中的代谢物与母体药物使用相关,如下所示
从采访和头发分析中获得。
本研究旨在开发胎便药物分析的潜力
作为一项全面的诊断测试。 目前,需要一个
新生儿时期客观、灵敏的测试,可以测量
婴儿接触药物的类型、数量、时间和持续时间
子宫。 评估胎便实现这一目标的潜力
提出分析。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Enrique Mapua Ostrea其他文献
Enrique Mapua Ostrea的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Enrique Mapua Ostrea', 18)}}的其他基金
Fetal Exposure to Environmental Toxicants and Child Outcome
胎儿接触环境毒物和儿童结局
- 批准号:
7458238 - 财政年份:2002
- 资助金额:
$ 24.85万 - 项目类别:
Fetal Exposure to Environmental Toxicants and Child Outcome
胎儿接触环境毒物和儿童结局
- 批准号:
7596434 - 财政年份:2002
- 资助金额:
$ 24.85万 - 项目类别:
Fetal Exposure to Environmental Toxicants and Child Outcome
胎儿接触环境毒物和儿童结局
- 批准号:
7799130 - 财政年份:2002
- 资助金额:
$ 24.85万 - 项目类别:
Fetal exposure to environmental toxins & infant outcome
胎儿接触环境毒素
- 批准号:
6434734 - 财政年份:2002
- 资助金额:
$ 24.85万 - 项目类别:
Fetal exposure to environmental toxins & infant outcome
胎儿接触环境毒素
- 批准号:
6621510 - 财政年份:2002
- 资助金额:
$ 24.85万 - 项目类别:
Fetal exposure to environmental toxins & infant outcome
胎儿接触环境毒素
- 批准号:
6709371 - 财政年份:2002
- 资助金额:
$ 24.85万 - 项目类别:
Fetal exposure to environmental toxins & infant outcome
胎儿接触环境毒素
- 批准号:
6881215 - 财政年份:2002
- 资助金额:
$ 24.85万 - 项目类别:
Fetal Exposure to Environmental Toxicants and Child Outcome
胎儿接触环境毒物和儿童结局
- 批准号:
8249782 - 财政年份:2002
- 资助金额:
$ 24.85万 - 项目类别:
Fetal Exposure to Environmental Toxicants and Child Outcome
胎儿接触环境毒物和儿童结局
- 批准号:
8055575 - 财政年份:2002
- 资助金额:
$ 24.85万 - 项目类别:
Fetal exposure to environmental toxins & infant outcome
胎儿接触环境毒素
- 批准号:
7028942 - 财政年份:2002
- 资助金额:
$ 24.85万 - 项目类别:
相似国自然基金
伏隔核D1受体神经元内质网应激关键分子在可卡因成瘾中的作用
- 批准号:82371498
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
丘脑束旁核至背内侧纹状体(Pf-DMS)痕迹环路介导可卡因成瘾及电针耳穴干预的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
可卡因合酶的底物偏好性机制及分子改造
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
上丘-蓝斑核-背侧海马神经环路在视觉线索诱发的可卡因觅药行为中的作用及机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:
蓝斑去甲肾上腺素神经元介导可卡因复吸行为的环路机理研究
- 批准号:82101568
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Integrated Behavioral Activation and HIV Risk Reduction Counseling for MSM with Stimulant Abuse
针对 MSM 滥用兴奋剂的综合行为激活和 HIV 风险降低咨询
- 批准号:
10335419 - 财政年份:2021
- 资助金额:
$ 24.85万 - 项目类别:
A Novel Workflow to Screen for Illicit Drug Exposure in Newborns
筛查新生儿非法药物暴露的新工作流程
- 批准号:
10162803 - 财政年份:2019
- 资助金额:
$ 24.85万 - 项目类别:
A Novel Workflow to Screen for Illicit Drug Exposure in Newborns
筛查新生儿非法药物暴露的新工作流程
- 批准号:
9912559 - 财政年份:2019
- 资助金额:
$ 24.85万 - 项目类别:
Characterization of cocaine induced signaling pathways that enhances HIV transcription
可卡因诱导的增强 HIV 转录的信号通路的表征
- 批准号:
9554849 - 财政年份:2017
- 资助金额:
$ 24.85万 - 项目类别:
Characterization of cocaine induced signaling pathways that enhances HIV transcription
可卡因诱导的增强 HIV 转录的信号通路的表征
- 批准号:
10399877 - 财政年份:2017
- 资助金额:
$ 24.85万 - 项目类别: